ABSTRACT We have studied the effects of the mucolytic thiol agent mercapto-ethanesulphonate (mesna) on the activity of both polymorphonuclear leucocyte (PMN) elastase and antileucoprotease in vitro. In all tests a specific synthetic substrate was used to measure elastase activity, which was then related to enzyme activity in the absence of mesna. The relative elastase activity decreased to 67 5% of control values after the enzyme had been incubated in a 120 mmol/I mesna solution. In the sol phase of purulent sputum, elastase activity decreased to 45% after the sol phase had been incubated in a 600 mmol/I mesna solution. The inability to reverse the inhibition of mesna by increasing the substrate concentration indicated that mesna acts as a non-competitive inhibitor of PMN elastase. Incubation of elastase with antileucoprotease reduced the relative elastase activity to 21%. When antileucoprotease was preincubated in a 60 mmol/I mesna solution under identical assay conditions, a relative elastase activity of 39% was observed. Inhibition experiments with mesna treated antileucoprotease, in which sulphydryl groups were blocked with iodoacetamide, strongly suggested that the dissociation constant (K;) of the fraction of antileucoprotease that retains activity after the incubation with mesna was not changed. Elastase inhibitory activity in mucoid sol phase, which can be ascribed mainly to antileucoprotease, decreased to 53% after incubation with mesna at a concentration of 960 mmol/l. Incubation of PMN elastase/antileucoprotease complex with mesna did not result in any release of active PMN elastase from the antileucoprotease. It is concluded that mesna and other thiol compounds, when locally administered, may influence the proteinase-antiproteinase balance in the airways by their effect on both PMN elastase and antileucoprotease.
The current theory of the pathogenesis of emphysema is that the destruction of lung elastin might be the result of a disequilibrium of the normal proteinaseantiproteinase balance within the lung, in which proteinase activity is in excess.' 2 This idea has evolved from the clinical experience with patients who have oc, proteinase inhibitor deficiency. These patients have decreased serum oc, proteinase inhibitor activity and develop panacinar emphysema during early adult life. A similar imbalance is created when increased numbers of polymorphonuclear leucocytes (PMN) are attracted to the lung, either by bacterial infection or by cigarette smoke.3 In addition, the destructive effect of PMN elastase on lung tissue might play a part in the adult respiratory distress syndrome,4 and its adverse effects on the mucociliary activity of respiratory epithelium may be important in patients with bronchiectasis and cystic fibrosis.5 '6 Antileucoprotease and oa, proteinase inhibitor are the major proteinase inhibitors in the respiratory tract. 7 Alpha, proteinase inhibitor is derived from serum and mainly produced by the liver,8 whereas antileucoprotease was found to be produced by the serous secretory cells of the submucosal glands9 and by non-ciliated cells of the bronchiolar epithelium."0 Alpha1 proteinase inhibitor is a more important inhibitor than antileucoprotease in peripheral airways,"l 12 whereas in bronchial fluids Tegner7 estimated that about 90% of the PMN elastase inhibition is caused by antileucoprotease.
Thiol compounds, which can be locally administered by nebulisers and are capable of reducing S-S bonds in mucoproteins to free sulphydryl groups, are In vitro effect of a mucolytic thiol agent on leucocyte elastase and antileucoprotease often used as mucolytic drugs. This study was designed to measure in vitro the effect of a thiol agent on the activity of both PMN elastase and antileucoprotease.
Methods

EFFECT OF THIOL AGENT ON PMN ELASTASE ACTI VITY
Crude PMN extracts were prepared by sonication of 17 x 106 polymorphonuclear leucocytes isolated from peripheral blood, in lml tris/NaCI buffer (0 1 mol/l tris; 0-96 mol/l NaCl; pH 8 3). Elastase activity in this extract was measured by using the specific substrate L-pyroglutamyl-L-prolyl-L-valine- 
Results
EFFECT OF THIOL AGENT ON PMN ELASTASE ACTIVITY
The PMN extract showed a mean absorbance increase of about 0-300/min under the conditions described. The effect of mesna on the elastase activity was also determined at different substrate concentrations. From the data obtained from this series of experiments, double reciprocal (Lineweaver-Burk) plots were constructed. These plots (fig lb) differ in slope and share a common intercept on the x-axis (= -I/KM). Thus inhibition by mesna does not have any influence on the Michaelis constant (KM). The intercept on they axis (l/v) is greater for the inhibited than for the uninhibited enzyme, indicating that the inhibition by mesna cannot be restored by high substrate concentration. When the same amount of antileucoprotease was preincubated with mesna before being mixed with PMN elastase, however, the remaining relative enzyme activity was found to be 32%. PMN elastase preincubated with antileucoprotease in excess and incubated with mesna afterwards did not show detectable enzyme activity. Stolk, Kramps, Dijkman buffer reduced the elastase activity in proportion to the mesna concentration (see fig 4) . The effect of mesna on the elastase inhibitor activity of mucoid sputum sol phase is shown in figure 5 . The dotted line has been obtained by correction of the uninhibited elastase activity for the direct effect of mesna on this enzyme. Calculations from these corrected data show that the highest mesna concentration used in this experiment resulted in an inhibitor activity that is only 53% of the inhibitor activity in the absence of mesna.
Discussion
Thiol compounds, such as dithiothreitol and glutathione, are able to inactivate enzymes by reducing S-S bonds to free sulphydryl groups. '5 Recently Biondy et al'6 used dithiothreitol to inactivate bovine trypsin inhibitor. In the present study the direct effects of a mucolytic thiol agent on the activity of PMN elastase, antileucoprotease, and their complex were studied. Effects of thiol on the activity of these compounds might have implications for the proteinaseantiproteinase balance within the lung. The inactivation of human PMN elastase and of antileucoprotease by mesna in vitro are the most important aspects of this study and suggest that disulphide bonds within the molecules are important for their integrity. Amino acid analysis has shown that purified PMN elastase contains about 6 and antileucoprotease 10-14 half cystine residues.9 14 17 In recent experiments we have found that antileucoprotease contains six disulphide bridges (unpublished result). Clearly mesna, which is a reducing agent by virtue of its sulphydryl group, is able to inactivate PMN elastase and antileucoprotease by splitting intrachain S-S bonds to form free sulphydryl groups.
It can be deduced from the Lineweaver-Burk plots shown in figure Ib that We thought that cystine containing mucoproteins, which are present in large amounts in sputum sol phase, might protect PMN elastase and antileucoprotease against inactivation by thiol agents. We found, however, that mesna was very effective in the inactivation of PMN elastase and antileucoprotease when these proteins are present in purulent and mucoid sputum sol phase respectively (figs 4 
and 5).
In experiments not presented here we found that the qualitative effects of the thiol agent acetyl cysteine on the activity of PMN elastase and antileucoprotease were similar to the effects of mesna (unpublished results).
From the results of this investigation, we conclude that administration of mucolytic thiol compounds by nebulisers might cause a reduction of free elastase activity or of free elastase inhibition activity in sputum. Stockley etal"9 reported a positive correlation between the PMN elastase activity in sputum and its purulence. Since PMN elastase is thought to be of major importance in destructive lung disease, decreasing the elastase load as much as possible seems rational. Thus, besides acting as mucolytic drugs, thiol compounds might protect the lung against proteolytic damage by inactivating part of the PMN elastase activity in patients producing purulent sputum. Administration of thiol compounds in patients producing mucoid sputum might, however, result in inactivation of antileucoprotease, which is the major elastase inhibitor in sputum. A more extensive investigation in patients producing sputum is needed to gain more knowledge about the in vivo effect of thiol compounds on the elastase activity and the elastase inhibitor activity in sputum. 
